SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A minor change in the total revenue was seen in the December 2022 quarter. The total revenue for the quarter stood at Rs. 10379.00 millions against Rs. 9901.00 millions during year ago period.Profit for the quarter ended December 2022 rises by 58.61% to Rs. 1345.00  millions from Rs. 848.00 millions.Operating profit for the quarter ended December 2022 rose to 1006.00 millions as compared to 761.00 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 10379.00 9901.00 4.83 41572.00 37711.00 10.24 47344.00 42613.00 11.10
Other Income 152.00 98.00 55.10 432.00 389.00 11.05 546.00 638.00 -14.42
PBIDT 1006.00 761.00 32.19 7616.00 6493.00 17.30 8657.00 8755.00 -1.12
Interest 34.00 26.00 30.77 150.00 74.00 102.70 129.00 126.00 2.38
PBDT 1979.00 1320.00 49.92 8473.00 7004.00 20.97 9113.00 8680.00 4.99
Depreciation 143.00 142.00 0.70 524.00 431.00 21.58 645.00 735.00 -12.24
PBT 1836.00 1178.00 55.86 7949.00 6573.00 20.93 8468.00 7945.00 6.58
TAX 491.00 330.00 48.79 1952.00 1647.00 18.52 2015.00 3014.00 -33.15
Deferred Tax 52.00 20.00 160.00 91.00 73.00 24.66 96.00 75.00 28.00
PAT 1345.00 848.00 58.61 5997.00 4926.00 21.74 6453.00 4931.00 30.87
Equity 449.00 449.00 0.00 449.00 449.00 0.00 449.00 449.00 0.00
PBIDTM(%) 9.69 7.69 26.11 18.32 17.22 6.40 18.29 20.55 -11.00

Bayer CropScience Share Price

4835.00 -65.45 (-1.34%)
20-Apr-2026 14:45 View Price Chart
Peers
Company Name CMP
UPL 657.90
PI Industries 3049.30
Bayer CropScience 4835.00
Sharda Cropchem 1101.55
Sumitomo Chemical 444.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×